1. Approved checkpoint inhibitors in bladder cancer: which drug should be used when?. (27th July 2018) Authors: Ghatalia, Pooja; Zibelman, Matthew; Geynisman, Daniel M.; Plimack, Elizabeth Journal: Therapeutic advances in medical oncology Issue: Volume 10(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Characterization of metastatic urothelial carcinoma via comprehensive genomic profiling of circulating tumor DNA. Issue 10 (8th March 2018) Authors: Agarwal, Neeraj; Pal, Sumanta K.; Hahn, Andrew W.; Nussenzveig, Roberto H.; Pond, Gregory R.; Gupta, Sumati V.; Wang, Jue; Bilen, Mehmet A.; Naik, Gurudatta; Ghatalia, Pooja; Hoimes, Christopher J.; Gopalakrishnan, Dharmesh; Barata, Pedro C.; Drakaki, Alexandra; Faltas, Bishoy M.; Kiedrowski, Les... Journal: Cancer Issue: Volume 124:Issue 10(2018) Page Start: 2115 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Checkpoint inhibitors for renal cell carcinoma: current landscape and future directions. (June 2016) Authors: Zibelman, Matthew; Ghatalia, Pooja; Geynisman, Daniel M; Plimack, Elizabeth R Journal: Immunotherapy Issue: Volume 8:Number 7(2016:Jul.) Page Start: 785 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Congestive heart failure with vascular endothelial growth factor receptor tyrosine kinase inhibitors. Issue 2 (May 2015) Authors: Ghatalia, Pooja; Morgan, Charity J.; Je, Youjin; Nguyen, Paul L.; Trinh, Quoc-Dien; Choueiri, Toni K.; Sonpavde, Guru Journal: Critical reviews in oncology/hematology Issue: Volume 94:Issue 2(2015) Page Start: 228 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Correction to: Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma. Issue 1 (22nd October 2019) Authors: Ghatalia, Pooja; Gordetsky, Jennifer; Kuo, Fengshen; Dulaimi, Essel; Cai, Kathy Q.; Devarajan, Karthik; Bae, Sejong; Naik, Gurudatta; Chan, Timothy A.; Uzzo, Robert; Hakimi, A. Ari; Sonpavde, Guru; Plimack, Elizabeth Journal: Journal for immunotherapy of cancer Issue: Volume 7:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Dual Checkpoint Inhibition with Ipilimumab plus Nivolumab After Progression on Sequential PD‐1/PDL‐1 Inhibitors Pembrolizumab and Atezolizumab in a Patient with Lynch Syndrome, Metastatic Colon, and Localized Urothelial Cancer. (23rd August 2019) Authors: Winer, Arthur; Ghatalia, Pooja; Bubes, Nicole; Anari, Fern; Varshavsky, Asya; Kasireddy, Vineela; Liu, Yang; El‐Deiry, Wafik S. Journal: Oncologist Issue: Volume 24:Number 11(2019) Page Start: 1416 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Fatigue with vascular endothelial growth factor receptor tyrosine kinase inhibitors and mammalian target of rapamycin inhibitors in patients with renal cell carcinoma (RCC) and other malignancies: A meta-analysis of randomized clinical trials. Issue 2 (August 2015) Authors: Ghatalia, Pooja; Je, Youjin; Nguyen, Paul L.; Trinh, Quoc-Dien; Choueiri, Toni K.; Sonpavde, Guru Journal: Critical reviews in oncology/hematology Issue: Volume 95:Issue 2(2015) Page Start: 251 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Hepatotoxicity with vascular endothelial growth factor receptor tyrosine kinase inhibitors: A meta-analysis of randomized clinical trials. Issue 3 (March 2015) Authors: Ghatalia, Pooja; Je, Youjin; Mouallem, Nemer El; Nguyen, Paul L.; Trinh, Quoc-Dien; Sonpavde, Guru; Choueiri, Toni K. Journal: Critical reviews in oncology/hematology Issue: Volume 93:Issue 3(2015) Page Start: 257 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Interaction of germline variants in a family with a history of early‐onset clear cell renal cell carcinoma. Issue 3 (24th January 2019) Authors: Nicolas, Emmanuelle; Demidova, Elena V.; Iqbal, Waleed; Serebriiskii, Ilya G.; Vlasenkova, Ramilia; Ghatalia, Pooja; Zhou, Yan; Rainey, Kim; Forman, Andrea F.; Dunbrack, Roland L.; Golemis, Erica A.; Hall, Michael J.; Daly, Mary B.; Arora, Sanjeevani Journal: Molecular genetics & genomic medicine Issue: Volume 7:Issue 3(2019) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Meta-analysis of regression of advanced solid tumors in patients receiving placebo or no anti-cancer therapy in prospective trials. (February 2016) Authors: Ghatalia, Pooja; Morgan, Charity J.; Sonpavde, Guru Journal: Critical reviews in oncology/hematology Issue: Volume 98(2016) Page Start: 122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗